Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 3024

1st Engrossment - 90th Legislature (2017 - 2018) Posted on 05/07/2018 03:06pm

KEY: stricken = removed, old language.
underscored = added, new language.

Bill Text Versions

Engrossments Comparisons
Introduction Posted on 03/28/2018
1st Engrossment Posted on 05/07/2018 compared with SF2836 1st Engrossment

Current Version - 1st Engrossment

Line numbers 1.1 1.2 1.3 1.4 1.5 1.6
1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17
1.18 1.19 1.20 1.21 2.1 2.2 2.3 2.4 2.5 2.6

A bill for an act
relating to health care; prohibiting a health plan company from contractually
preventing a pharmacist from informing a patient of a price differential; establishing
a standard for prescription cost to consumers; amending Minnesota Statutes 2016,
sections 151.214, subdivision 2; 151.71, by adding a subdivision.


Section 1.

Minnesota Statutes 2016, section 151.214, subdivision 2, is amended to read:

Subd. 2.

No prohibition on disclosure.

No contracting agreement between an
employer-sponsored health plan or health plan company, or its contracted pharmacy benefit
manager, and a resident or nonresident pharmacy deleted text beginregistereddeleted text endnew text begin licensednew text end under this chapter,
may prohibit deleted text beginthedeleted text endnew text begin:
new text end

new text begin (1) anew text end pharmacy from disclosing to patients information a pharmacy is required or given
the option to provide under subdivision 1new text begin; or
new text end

new text begin (2) a pharmacist from informing a patient when the amount the patient is required to
pay under the patient's health plan for a particular drug is greater than the amount the patient
would be required to pay for the same drug if purchased out-of-pocket at the pharmacy's
usual and customary price
new text end.

Sec. 2.

Minnesota Statutes 2016, section 151.71, is amended by adding a subdivision to

new text begin Subd. 3. new text end

new text begin Lowest cost to consumers. new text end

new text begin (a) A health plan company or pharmacy benefits
manager shall not require an individual to make a payment at the point of sale for a covered
prescription medication in an amount greater than the allowable cost to consumers, as
defined in paragraph (b).
new text end

new text begin (b) For purposes of paragraph (a), "allowable cost to consumers" means the lowest of:
(1) the applicable co-payment for the prescription medication; or (2) the amount an individual
would pay for the prescription medication if the individual purchased the prescription
medication without using a health plan benefit.
new text end